✦ LIBER ✦

Premorbid abnormalities in mania, schizomania, acute schizophrenia and chronic schizophrenia

✍ Scribed by J. Os; N. Takei; D. J. Castle; S. Wessely; G. Der; R. M. Murray

Publisher: Springer-Verlag
Year: 1995
Tongue: English
Weight: 527 KB
Volume: 30
Category: Article
ISSN: 1433-9285
DOI: 10.1007/bf00805794

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Plasma haloperidol levels and therapeuti

Plasma haloperidol levels and therapeutic response in acute mania and schizophrenia

✍ A. E. Balant-Gorgia; R. Eisele; L. Balant; G. Garrone 📂 Article 📅 1984 🏛 Springer-Verlag 🌐 English ⚖ 350 KB

In an open study, 18 patients suffering from an acute episode of schizophrenia and 18 patients with severe mania were given haloperidol at different dosage levels. Haloperidol plasma concentrations were measured and the status of the patients was evaluated at intervals using the Brief Psychiatric Ra

Abnormal changes of plasma acute phase p

Abnormal changes of plasma acute phase proteins in schizophrenia and the relation between schizophrenia and haptoglobin (Hp) gene

✍ C. Wan; Y. La; H. Zhu; Y. Yang; L. Jiang; Y. Chen; G. Feng; H. Li; H. Sang; X. H 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 150 KB

Rey-osterrieth complex figure test perfo

Rey-osterrieth complex figure test performance in acute, chronic, and remitted schizophrenia patients

✍ Steven M. Silverstein; Leah M. Osborn; Donna R. Palumbo 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 103 KB

To assess visual memory disturbance in different forms of schizophrenia, we compared Rey-Osterrieth Complex Figure Test (RCF) performance in acutely psychotic, chronically psychotic, and outpatient schizophrenia patients and in a control group of acutely psychotic patients with disorders other than

Use of an acute challenge with d-ampheta

Use of an acute challenge with d-amphetamine to model cognitive improvement in chronic schizophrenia

✍ Robert H. Pietrzak; Peter J. Snyder; Paul Maruff 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 75 KB

## Abstract There is general agreement that pharmacologic improvement of cognition in chronic schizophrenia is a worthwhile therapeutic goal. Accordingly, there has been careful consideration about how neuropsychological methods can be used to detect improvement in cognition in people with schizoph

An observational study of the effectiven

An observational study of the effectiveness and safety of intramuscular olanzapine in the treatment of acute agitation in patients with bipolar mania or schizophrenia/schizoaffective disorder

✍ Franca Centorrino; Adam L. Meyers; Jonna Ahl; Stephanie L. Cincotta; Leslie Zun; 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 114 KB 👁 2 views

## Abstract ## Objective To determine the effect of intramuscular (IM) olanzapine in severely agitated patients. ## Methods This was an open‐label multicenter 1‐week observational study of IM olanzapine treatment in severely agitated inpatients and psychiatric emergency services with bipolar man

Dopamine receptor D3 genotype associatio

Dopamine receptor D3 genotype association with greater acute positive symptom remission with olanzapine therapy in predominately caucasian patients with chronic schizophrenia or schizoaffective disorder

✍ David H. Adams; Sandra Close; Mark Farmen; AnnCatherine M. Downing; Alan Breier; 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 154 KB

## Abstract ## Objective To test association of dopamine receptor D3 (DRD‐3) gene polymorphisms with olanzapine response in genetic samples from a registration phase clinical trial. ## Methods Eighty‐eight acutely ill patients with schizophrenia or schizoaffective disorder were genotyped for ser